Insmed
INSM
#958
Rank
A$36.38 B
Marketcap
A$165.85
Share price
5.19%
Change (1 day)
-43.84%
Change (1 year)

EPS for Insmed (INSM)

EPS in 2023 (TTM): A-$7.92

According to Insmed's latest financial reports the company's current EPS (TTM) is A-$4.09. In 2022 the company made an earnings per share (EPS) of A-$5.65 a decrease over its 2021 EPS that were of A-$5.61.

EPS history for Insmed from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$7.9240.13%
2022A-$5.650.78%
2021A-$5.6128.57%
2020A-$4.36-0.99%
2019A-$4.41-27.96%
2018A-$6.1247.55%
2017A-$4.150.7%
2016A-$4.1239.9%
2015A-$2.949.73%
2014A-$2.6817.09%
2013A-$2.290.64%
2012A-$2.28-46.42%
2011A-$4.25497.96%
2010A-$0.71-105.1%
2009A$13.93-850.78%
2008A-$1.86-24.71%
2007A-$2.46-71.67%
2006A-$8.70-28.57%
2005A-$12.1823.53%
2004A-$9.86134.48%
2003A-$4.20-73.64%
2002A-$15.95-2.65%
2001A-$16.38-86.64%
2000A-$122.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.61-286.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A-$4.49 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$25.12-714.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A-$3.81-6.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.09-73.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A-$1.42-65.25%๐Ÿ‡บ๐Ÿ‡ธ USA